Back to Journals » Therapeutics and Clinical Risk Management » Volume 10

Emerging treatments in type 2 diabetes: focus on canagliflozin

Total article views   HTML views PDF downloads Totals
9,956 Dovepress* 7,902+ 2,328 10,230
PubMed Central* 2,054 939 2,993
Totals 9,956 3,267 13,223
*Since 21 August 2014
+Since July 2016

View citations on PubMed Central and Google Scholar